The number of people with susceptibility test result for rifampicin in Central African Republic
Central African Republic: The number of people with susceptibility test result for rifampicin was 660 in 2021. ◆ Volatile
Latest (2021)
660
Change on year
down 1.6%
World rank
73rd
of 155 countries
All-time high
671
in 2020
All-time low
17
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Central African Republic, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Central African Republic recorded 660 for the number of people with susceptibility test result for rifampicin in 2021.
Compared with earlier readings it is down 1.6% on the previous year and up 3,782.3% over five years.
Central African Republic ranks 73rd of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Central African Republic, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 17 | — |
| 2018 | 37 | +117.6% |
| 2019 | 251 | +578.4% |
| 2020 | 671 | +167.3% |
| 2021 | 660 | -1.6% |
Central African Republic compared with similar countries
- Central African Republic's 660 is below the median for low income countries, which is 1,934, 34% of the median. (15 countries reporting)
- Central African Republic's 660 is below the median for Sub-Saharan Africa, which is 2,015, 33% of the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 101.67 | 17 | 251 | 3 |
| 2020s | 665.5 | 660 | 671 | 2 |
Countries ranked near Central African Republic
More health data for Central African Republic
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.15 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 887.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5,728 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 4.9 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0002 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0934 units per person (2025)
- Population ages 00-04, male, annual growth rate 4.96 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0002 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Central African Republic?
- The number of people with susceptibility test result for rifampicin in Central African Republic was 660 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Central African Republic?
- The highest recorded value was 671 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Central African Republic?
- The lowest recorded value was 17 in 2017.
- How does Central African Republic rank for the number of people with susceptibility test result for rifampicin?
- Central African Republic ranks 73rd out of 155 countries with data for 2021.
- Where does this Central African Republic data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).